Stocks to watch out for today: KPIT Tech, RIL, Tata Steel, Biocon and more

[ad_1] The domestic equity market closed higher on Friday. Sensex rose 242 points to end the session at 71,106 and Nifty gained 94 points to settle at 21,439. Here’s a…

How Devyani International’s global expansion will be gamechanger for Thailand QSR market- Republic World

[ad_1] The foray into Thailand market sparked a rally in the stock on Tuesday as it surged as much as 7.62 per cent to hit an intraday high of Rs…

Biocon Says Not Evaluating Divestment Options For API Business

[ad_1] In a regulatory filing, Bengaluru-based company said it is “neither evaluating any divestment options for its API business nor consulting any bankers for this.” The Active Pharmaceutical Ingredient (API)…

Biocon integrates biosimilars business of Viatris in 31 countries

[ad_1] Biocon Biologics has completed the integration of Viatris’ biosimilars business across countries in Europe. Credit: Biocon. Biocon subsidiary Biocon Biologics has successfully integrated Viatris‘ biosimilars business in 31 countries…

Biocon’s subsidiary completes integration of Viatris’ biosimilars business; stock rises

[ad_1] Biocon share price: Biocon shares on Friday, December 1, rose over 2 per cent to touch the intra-day high of Rs 245 apiece on BSE, rising for the third…

Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe

[ad_1] BENGALURU, India, Nov. 30, 2023 /PRNewswire/ — Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris’ biosimilars business…

Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada

[ad_1] Global biopharmaceutical company Biocon announced on Friday a partnership with Juno Pharmaceuticals, a specialty pharmaceutical firm based in Canada, for the commercialisation of Liraglutide, a drug-device combination intended for…

Biocon acquires Eywa Pharma’s New Jersey facility for $7.7 million

[ad_1] Biocon Ltd has announced the acquisition of Eywa Pharma Inc’s oral solid dosage manufacturing facility by its step-down, wholly owned subsidiary, Biocon Generics Inc, for $7.7 million. The biotechnology giant stated…

Biocon may list biosimilars business by 2025 first half – CEO

[ad_1] An employee of Biocon Ltd works inside the company’s research and development centre in Bengaluru, India, October 16, 2015. REUTERS/Abhishek N. Chinnappa/File Photo HYDERABAD, Aug 11 (Reuters) – Indian…

Stock Market Live: GIFT Nifty Signals Higher Open; HCL Tech, DLF, Zee, Hero Moto, LIC, Biocon In Focus

[ad_1] Hero MotoCorp Q1FY24 (Standalone, YoY) Revenue up 4% to Rs 8,767.3 crore Vs Rs 8,392.5 crore (Bloomberg Estimate: Rs 8,958 crore) Net profit up 32% at Rs 824.7 crore…